IA
EDIT icon

IFP Advisors’s Editas Medicine EDIT Stock Holding History

IFP Advisors’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-1,500
Closed -$36K – 3872
2017
Q3 		$36K Buy
+1,500
New +$28.6K ﹤0.01% 2200

Other funds holding EDIT

Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
TWM
Thrive Wealth Management Audubon, Pennsylvania $787M AUM 23.6% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return
DIM
DLK Investment Management Solana Beach, California $235M AUM 12.41% 1-Year Est. Return
IFG
Independent Financial Group San Diego, California $5.35B AUM 43.78% 1-Year Est. Return
AHL
Abel Hall LLC Baton Rouge, Louisiana $579M AUM 54.21% 1-Year Est. Return
AWM
Aries Wealth Management Portland, Maine $509M AUM 25.6% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return

IFP Advisors's EDIT Position: Q2 2026 in Review

IFP Advisors increased its Editas Medicine (EDIT) stake by 24% in Q2 2026, buying an estimated $289 and bringing the position to 506 shares worth $1.64K. The position accounts for ﹤0.01% of the portfolio, ranked #4322.

IFP Advisors first reported a position in EDIT in Q1 2016 and has held it in 32 quarters since. The position peaked at $47K in Q3 2022. 35 funds tracked by Wall St. Rank hold EDIT as of Q2 2026.

  • IFP Advisors held 506 shares of Editas Medicine worth $1.64K as of Q2 2026.
  • IFP Advisors bought 99 Editas Medicine shares in Q2 2026, an estimated $289.
  • Editas Medicine made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #4322 holding.
  • IFP Advisors first reported a position in Editas Medicine in Q1 2016 and has held it in 32 quarters since.
  • IFP Advisors's Editas Medicine position peaked at $47K in Q3 2022.
  • 35 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2026.

Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.